Michael Heffernan
Interim President and CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Collegium Pharmaceutical, Inc (COLL) | R.Ph. Former Interim President and Chief Executive Officer | $135,737 | $466,455 |
| 2023 | Collegium Pharmaceutical, Inc (COLL) | R.Ph. Former Interim President and Chief Executive Officer | — | — |
| 2022 | Collegium Pharmaceutical, Inc (COLL) | R.Ph. Former Interim President and Chief Executive Officer | — | — |
Executive changes
Earnings-call appearances
-
Collegium Pharmaceutical, Inc Q3 FY2024 Earnings Call2024-11-07
Collegium Pharmaceutical, Inc (COLL)
-
Collegium Pharmaceutical, Inc Q1 FY2024 Earnings Call2024-05-09
Collegium Pharmaceutical, Inc (COLL)